T32 Research Grant
Research at the University of Pittsburgh is funded by the National Institute of Health T32 Research Grant. We offer an extensive array of research areas to choose from to meet the interests of the applicant, whether it be basic, clinical or translational research. Salary is commensurate with post-graduate level.
Applicants must have a doctorate degree and be either a United States citizen or permanent resident (due to the nature of the grant).
To apply for July 1, 2024 start date, please send
CV and cover letter to
Amanda Pippi at hickeyab2@upmc.edu
Join our leading researchers in cancer care for individualized training at one of the best hospitals in the country. Our research is consistently innovative and world-renowned, improving countless lives.
Areas of Research
Head and Neck Cancer
Oncologic Immunology
Oncologic Epidemiology
Disparities
Biostatistics
Molecular Biology
Genetics
Thyroid Pathology
Biomedical Informatics
Oncologic Neurobiology
Publications
Molkentine DP, Molkentine JM, Bridges KA, Valdecanas DR, Dhawan A, Bahri R, Hefner AJ, Kumar M, Yang L, Abdelhakiem M, Pifer PM, Sandulache V, Sheth A, Beadle BM, Thames HD, Mason KA, Pickering CR, Meyn RE, Skinner HD. p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade. Cancer Res. 2022 Mar 1;82(5):916-928. PMID: 34965932
Kulkarni S, Bill A, Godse NR, Khan NI, Kass JI, Steehler K, Kemp C, Davis K, Bertrand CA, Vyas AR, Holt DE, Grandis JR, Gaither LA, Duvvuri U. TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2. Genes Chromosomes Cancer. 2017 Jun;56(6):460-471. Epub 2017 Apr 3. PMID: 28177558
Mady LJ, Grimes MC, Khan NI, Rao RH, Chiosea SI, Yip L, Ferris RL, Nikiforov YE, Carty SE, Duvvuri U. Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers. Sci Rep. 2020 May 15;10(1):8031. PMID: 32415114